Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
YcCdMJMT96x2uWWT